|Bid||65.87 x 1200|
|Ask||66.00 x 2900|
|Day's Range||65.41 - 66.21|
|52 Week Range||56.67 - 67.96|
|Beta (5Y Monthly)||0.62|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 28, 2021|
|Forward Dividend & Yield||1.96 (3.00%)|
|Ex-Dividend Date||Jul 01, 2021|
|1y Target Est||75.37|
Investors can buy low cost index fund if they want to receive the average market return. But if you invest in...
Is BMY stock a buy after Bristol Myers Squibb said a cancer drug called Breyanzi outperformed the standard treatment in patients with a form of lymphoma?
Bristol Myers (BMY) wins approval for acute myeloid leukemia drug, Onureg, in the European Union.